Your browser doesn't support javascript.
loading
Whole Exome Sequencing Identifies Frequent Somatic Mutations in Cell-Cell Adhesion Genes in Chinese Patients with Lung Squamous Cell Carcinoma.
Li, Chenguang; Gao, Zhibo; Li, Fei; Li, Xiangchun; Sun, Yihua; Wang, Mengyun; Li, Dan; Wang, Rui; Li, Fuming; Fang, Rong; Pan, Yunjian; Luo, Xiaoyang; He, Jing; Zheng, Liangtao; Xia, Jufeng; Qiu, Lixin; He, Jun; Ye, Ting; Zhang, Ruoxin; He, Minghui; Zhu, Meiling; Hu, Haichuan; Shi, Tingyan; Zhou, Xiaoyan; Sun, Menghong; Tian, Shilin; Zhou, Yong; Wang, Qiaoxiu; Chen, Longyun; Yin, Guangliang; Lu, Jingya; Wu, Renhua; Guo, Guangwu; Li, Yingrui; Hu, Xueda; Li, Lin; Wang, Qin; Yin, Ye; Feng, Qiang; Wang, Bin; Wang, Hang; Wang, Mingbang; Yang, Xiaonan; Zhang, Xiuqing; Yang, Huanming; Jin, Li; Wang, Cun-Yu; Ji, Hongbin; Chen, Haiquan; Wang, Jun.
Afiliação
  • Li C; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Gao Z; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Li F; BGI-Shenzhen, Shenzhen, 518083, China.
  • Li X; State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Science, Shanghai, 200031, China.
  • Sun Y; BGI-Shenzhen, Shenzhen, 518083, China.
  • Wang M; Department of Medicine and Therapeutics, State Key Laboratory of Digestive. Disease, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong.
  • Li D; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Wang R; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Li F; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Fang R; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Pan Y; BGI-Shenzhen, Shenzhen, 518083, China.
  • Luo X; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • He J; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Zheng L; State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Science, Shanghai, 200031, China.
  • Xia J; State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Science, Shanghai, 200031, China.
  • Qiu L; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • He J; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Ye T; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Zhang R; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • He M; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Zhu M; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Hu H; BGI-Shenzhen, Shenzhen, 518083, China.
  • Shi T; State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Science, Shanghai, 200031, China.
  • Zhou X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Sun M; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Tian S; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Zhou Y; BGI-Shenzhen, Shenzhen, 518083, China.
  • Wang Q; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Chen L; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Yin G; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Lu J; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Wu R; BGI-Shenzhen, Shenzhen, 518083, China.
  • Guo G; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Li Y; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Hu X; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Li L; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Asan; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Wang Q; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Yin Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Feng Q; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Wang B; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Wang H; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Wang M; BGI-Shenzhen, Shenzhen, 518083, China.
  • Yang X; BGI-Shenzhen, Shenzhen, 518083, China.
  • Zhang X; BGI-Shenzhen, Shenzhen, 518083, China.
  • Yang H; BGI-Shenzhen, Shenzhen, 518083, China.
  • Jin L; BGI-Shenzhen, Shenzhen, 518083, China.
  • Wang CY; BGI-Shenzhen, Shenzhen, 518083, China.
  • Ji H; BGI-Shenzhen, Shenzhen, 518083, China.
  • Chen H; BGI-Shenzhen, Shenzhen, 518083, China.
Sci Rep ; 5: 14237, 2015 Oct 27.
Article em En | MEDLINE | ID: mdl-26503331
ABSTRACT
Lung squamous cell carcinoma (SQCC) accounts for about 30% of all lung cancer cases. Understanding of mutational landscape for this subtype of lung cancer in Chinese patients is currently limited. We performed whole exome sequencing in samples from 100 patients with lung SQCCs to search for somatic mutations and the subsequent target capture sequencing in another 98 samples for validation. We identified 20 significantly mutated genes, including TP53, CDH10, NFE2L2 and PTEN. Pathways with frequently mutated genes included those of cell-cell adhesion/Wnt/Hippo in 76%, oxidative stress response in 21%, and phosphatidylinositol-3-OH kinase in 36% of the tested tumor samples. Mutations of Chromatin regulatory factor genes were identified at a lower frequency. In functional assays, we observed that knockdown of CDH10 promoted cell proliferation, soft-agar colony formation, cell migration and cell invasion, and overexpression of CDH10 inhibited cell proliferation. This mutational landscape of lung SQCC in Chinese patients improves our current understanding of lung carcinogenesis, early diagnosis and personalized therapy.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Adesão Celular / Análise de Sequência / Exoma / Neoplasias Pulmonares / Mutação Tipo de estudo: Prognostic_studies / Screening_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Sci Rep Ano de publicação: 2015 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Adesão Celular / Análise de Sequência / Exoma / Neoplasias Pulmonares / Mutação Tipo de estudo: Prognostic_studies / Screening_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Sci Rep Ano de publicação: 2015 Tipo de documento: Article País de afiliação: China